Study of ayurved drug preparation gokshura and shatavari tablet in treatment of pittaj mutrakruchra Urinary tract infection

To Study the effect of Gokshura and Shatavari in Pittaj Mutrakruchra

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032395

Enrollment

400

Registered

2021-03-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Gokshur shatavari: Gokshura Shatavari vati 500mg tds for 7 days Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical sign and symptoms of pittaj mutrakruchra Sashool mutrapravrutti sadah mutrapravrutti Sarakta mutrapravrutti Alpa alpa mutrapravrutti alpa udarshool

Exclusion criteria

Exclusion criteria: Patients having phimosis or paraphimosis Presence of pus cells more than 15 hpf in urine Presence of RBC more than 10 hpf i urine Patients suffering from severe systemic disorders Patients having uncontrolled bowl bladder

Design outcomes

Primary

Measure	Time frame
Reduction in Pus cells in urine Reduction in sign and symptoms of mutrakruchraTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Reduction in RBC in UrineTimepoint: 7 14 21 28 day	—

Countries

India

Contacts

Public ContactDr Parag Deshmukhe

Parul University Vadodara Gujrat

naresh.kore86275@paruluniversity.ac.in8275174623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026